Scienture Holdings, Inc.
SCNX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $1 | $10 | $10 |
| % Growth | -90% | -86.7% | 3.6% | – |
| Cost of Goods Sold | $0 | $1 | $5 | $5 |
| Gross Profit | $0 | $0 | $6 | $5 |
| % Margin | 4.4% | 3.6% | 53.8% | 48% |
| R&D Expenses | $2 | $0 | $1 | $1 |
| G&A Expenses | $12 | $4 | $7 | $8 |
| SG&A Expenses | $12 | $4 | $7 | $8 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $1 | $2 |
| Operating Expenses | $15 | $4 | $8 | $10 |
| Operating Income | -$15 | -$4 | -$3 | -$5 |
| % Margin | -10,758.7% | -322.4% | -28.4% | -53.5% |
| Other Income/Exp. Net | -$4 | -$4 | $1 | -$0 |
| Pre-Tax Income | -$19 | -$8 | -$2 | -$5 |
| Tax Expense | -$1 | $0 | $0 | $0 |
| Net Income | $9 | -$18 | -$3 | -$5 |
| % Margin | 6,634.7% | -1,308.3% | -33.9% | -53.8% |
| EPS | 2.69 | -23.35 | -6.15 | -9.8 |
| % Growth | 111.5% | -279.7% | 37.2% | – |
| EPS Diluted | 2.48 | -7.49 | -6.15 | -9.8 |
| Weighted Avg Shares Out | 3 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 4 | 2 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $0 | $0 |
| Depreciation & Amortization | $0 | $1 | $0 | $0 |
| EBITDA | -$17 | -$6 | -$2 | -$5 |
| % Margin | -12,726.5% | -461.2% | -18.3% | -52.1% |